Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defining a future role for radiogenic therapy.

J M Kaminski1, R J Kaminski, A P Dicker

  • 1Department of Radiology, Medical College of Georgia, Augusta 30912, USA. JM_Kaminski@FCCC.edu

Cancer Treatment Reviews
|March 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.

Prostate cancer and prostatic diseases·2016
Same author

The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?

British journal of cancer·2014
Same author

Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets.

British journal of cancer·2014
Same author

Association between metabolic syndrome, diabetes mellitus and prostate cancer risk.

Prostate cancer and prostatic diseases·2013
Same author

Implementation and experimental results of 4D tumor tracking using robotic couch.

Medical physics·2012
Same author

Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same journal

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Cancer treatment reviews·2026
Same journal

Treatment of breast cancer brain metastases in the era of novel drugs.

Cancer treatment reviews·2026
Same journal

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same journal

Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

Cancer treatment reviews·2026
Same journal

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Cancer treatment reviews·2026
Same journal

Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes.

Cancer treatment reviews·2026
See all related articles

Radiogenic therapy utilizes radiation to activate cancer treatments, enhancing effectiveness and reducing harm to healthy tissues. This approach aims to improve cancer treatment outcomes by leveraging radiation-inducible mechanisms.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Molecular Therapy

Background:

  • Cancer therapy aims to eradicate tumors while minimizing damage to normal tissues, thereby improving the therapeutic ratio.
  • Conventional treatments often face challenges in selectively targeting cancer cells and managing side effects.
  • Novel therapeutic strategies are needed to enhance treatment efficacy and patient outcomes.

Purpose of the Study:

  • To review a novel class of therapeutics termed 'radiogenic therapy'.
  • To categorize radiogenic therapies based on their mechanisms of radiation-inducible action.
  • To highlight the potential of these therapies in improving cancer treatment outcomes.

Main Methods:

  • Review of existing literature on radiation-inducible gene expression and targeted radionuclide therapy.

Related Experiment Videos

  • Categorization of radiogenic therapies into three main groups based on their mode of action.
  • Analysis of the mechanisms by which radiation stimulates or is utilized by these therapeutic agents.

    • Main Results:

    • Radiogenic therapies encompass agents directly activated by radiation, radiolabeled molecules targeting internalized cancer cells, and radiation-inducible genes that facilitate targeted delivery of cytotoxic agents.
    • These therapies leverage radiation-inducible promoters to control the expression of cytotoxic proteins or prodrug-converting enzymes.
    • Internalized Auger-electron emitting agents and radiation-inducible gene products for targeted delivery represent distinct but complementary approaches.

    Conclusions:

    • Radiogenic therapy represents a promising strategy for enhancing cancer treatment by harnessing radiation's dual role in both targeting and activation.
    • The diverse mechanisms within radiogenic therapy offer flexibility in designing targeted and effective cancer treatments.
    • Further research and development in radiogenic therapy hold significant potential for improving the therapeutic ratio in oncology.